Home / Companies / Worldwide Clinical Trials Early Phase Services Bioanalytical Sciences Llc / Trends
Worldwide Clinical Trials Early Phase Services Bioanalytical Sciences Llc H-1B trends
Quarterly LCA aggregate trend points for Worldwide Clinical Trials Early Phase Services Bioanalytical Sciences Llc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
Worldwide Clinical Trials Early Phase Services Bioanalytical Sciences Llc recorded 3 H-1B LCA filings in 2023 Q4.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 3 | 2 | 2 | $93,333 | $72,016 | 3 | 100.0% |
Frequently asked questions
- How have H-1B filings for Worldwide Clinical Trials Early Phase Services Bioanalytical Sciences Llc changed over time?
- Worldwide Clinical Trials Early Phase Services Bioanalytical Sciences Llc recorded 3 H-1B LCA filings in 2023 Q4. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=worldwide+clinical+trials+early+phase+services+bioanalytical+sciences+llc&metric=lca_countJSON